Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Huntsman Cancer Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Huntsman Cancer Institute brings 25 presentations to ASH 2026 in New Orleans. Its research spans lymphoma, leukemia and blood clotting. It covers PD-1 retreatment in relapsed Hodgkin lymphoma, avapritinib dose increases in indolent systemic mastocytosis and hormonal therapy in women starting anticoagulants.

OrganizationASH 2026 Attendance
Huntsman Cancer Institute
Salt Lake City, UT
Hospitals & cancer centres
NCI-designated cancer center at the University of Utah in Salt Lake City, combining research and patient care.
Talk
Mon Dec 14
4:30pm–5:45pm
Inherited Methemoglobinemia: Not Only and Not Always Cyanosis. Different Pathophysiology, Different Mutated Genes, and Different Management
The genetic causes of inherited methemoglobinemia, rooted in faulty methemoglobin reduction, with their varied symptoms, diagnosis and management.
Red cells

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Huntsman Cancer Institute

Tell us what you sell and we’ll find the people at Huntsman Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction